PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib

The synthetic lethal association between BRCA deficiency and poly (ADP-ribose) polymerase (PARP) inhibition supports PARP inhibitor (PARPi) clinical efficacy in BRCA-mutated tumors. PARPis also demonstrate activity in non-BRCA mutated tumors presumably through induction of PARP1-DNA trapping. Despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xia, Zhu, Zhou, Lapek, John, McMillan, Elizabeth A., Zhang, Alexander, Chung, Chi-Yeh, Dubbury, Sara, Lapira, Jennifer, Firdaus, Sarah, Kang, Xiaolin, Gao, Jingjin, Oyer, Jon, Chionis, John, Rollins, Robert A., Li, Lianjie, Niessen, Sherry, Bagrodia, Shubha, Zhang, Lianglin, VanArsdale, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304387/
https://www.ncbi.nlm.nih.gov/pubmed/35864202
http://dx.doi.org/10.1038/s41598-022-16623-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304387/
https://www.ncbi.nlm.nih.gov/pubmed/35864202
http://dx.doi.org/10.1038/s41598-022-16623-3

Ejemplares similares